V. Egan et al., THE EDINBURGH COHORT OF HIV-POSITIVE DRUG-USERS - THE EFFECTS OF DEPRESSED MOOD AND DRUG-USE UPON NEUROPSYCHOLOGICAL FUNCTION, British journal of health psychology, 1, 1996, pp. 231-244
The effect of the human immunodeficiency virus (HIV) on cognitive func
tion drug users is subject to the effects of drug use and depression.
The current study tested the effect of these potential confounders in
244 HIV-positive drug users (147 asymptomatic, 97 symptomatic) and 42
confirmed HIV-negative drug users. No difference was found between HIV
-positive and HIV-negative groups for measures of drug use, negative m
ood, or verbal IQ. Symptomatic HIV-positive patients were significantl
y more impaired on measures of non-verbal performance intelligence and
memory than HIV-negative or HIV-positive asymptomatic patients. Struc
tural modelling of the data suggested associations between failing CD4
count and impaired non-verbal performance; low mood, greater benzodia
zepine use and poorer memory; and higher opiate use and slight impairm
ent on non-verbal performance. Drug use and low mood did not act upon
low CD4 count to affect non-verbal cognitive performance. Our results
suggest cognitive impairment in HIV-positive drug users attributable t
o HIV illness can be detected, and that concurrent drug use and mood a
re not major confounders, provided such factors are recognized to begi
n with.